7,556.25

-18.25

-0.24%

51,638.00

-495.00

-0.95%

28,117.75

-9.75

-0.03%

Russell 2000 Futures

2,810.40

-7.40

-0.26%

4.8940

-0.0350

-0.71%

21.59

+0.44

+2.08%

3,914.10

-55.50

-1.40%

76,984.82

-689.42

-0.89%

Crude Oil Dec 26

98.54

+2.08

+2.16%

US Private Equity

10,836.30

-14.33

-0.13%

NasdaqCM - Nasdaq Real Time Price USD

Mereo BioPharma Group plc (MREO)

0.2900 +0.0005 (+0.17%)

At close: November 2 at 4:00:02 PM EST

0.2882 -0.0018 (-0.62%)

Pre-Market: 6:42:09 AM EST

Loading Chart for MREO

Chart Range Bar

Interval:

In partnership with ChartIQ

Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights

Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights

Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading

European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

We're Hopeful That Mereo BioPharma Group (NASDAQ:MREO) Will Use Its Cash Wisely

We're Hopeful That Mereo BioPharma Group (NASDAQ:MREO) Will Use Its Cash Wisely

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading

Mobilize your Website

View Site in Mobile | Classic

Share by: